Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)

Showing 151 - 160 of 183 results

First page
Previous page
16
Next page
Next page

OLAPTESED PEGOL

MTM792B442

Sequence Search

Status:

Investigational

Source:

NCT04121455: Phase 1/Phase 2 Interventional Active, not recruiting Glioblastoma

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04121455

Class:

NUCLEIC ACID

VOCIMAGENE AMIRETROREPVEC

DC4WO3WA4Q

Status:

Investigational

Source:

NCT04105374: Phase 2/Phase 3 Interventional Withdrawn Anaplastic Astrocytoma

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04105374

Class:

STRUCTURALLY DIVERSE

ENADENOTUCIREV

KX7ZYR6OQW

Status:

Investigational

Source:

NCT02028442: Phase 1/Phase 2 Interventional Completed Solid Tumours of Epithelial Origin

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02028442

Class:

STRUCTURALLY DIVERSE

CANERPATUREV

O3F5D10T4M

Status:

Investigational

Source:

NCT03252808: Phase 1 Interventional Active, not recruiting Pancreatic Cancer Stage III

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03252808

Class:

STRUCTURALLY DIVERSE

PELAREOREP

S9J80L3D1U

Status:

Investigational

Source:

NCT04215146: Phase 2 Interventional Active, not recruiting Breast Cancer Metastatic

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04215146

Class:

STRUCTURALLY DIVERSE

GEBASAXTUREV

4B57CWT710

Status:

Investigational

Source:

NCT01636882: Phase 2 Interventional Completed Melanoma

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01636882

Class:

STRUCTURALLY DIVERSE

PF-06747143

7TS9C20ZWA

Status:

Investigational

Source:

NCT02954653: Phase 1 Interventional Terminated Acute Myeloid Leukemia

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02954653

Class:

CONCEPT

SGN-CD123A

89ATB9I3D2

Status:

Investigational

Source:

NCT02848248: Phase 1 Interventional Terminated Acute Myeloid Leukemia

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02848248

Class:

CONCEPT

HKT-288

94ZE6ON35F

Status:

Investigational

Source:

NCT02947152: Phase 1 Interventional Terminated Epithelial Ovarian Cancer

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02947152

Class:

CONCEPT

CDX-3379

00X6I56YXR

Status:

Investigational

Source:

NCT02473731: Phase 1 Interventional Completed Squamous Cell Carcinoma of the Head and Neck

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02473731

Class:

CONCEPT

Nucleic Acid

OLAPTESED PEGOL

Structurally Diverse

VOCIMAGENE AMIRETROREPVEC

Structurally Diverse

Structurally Diverse

CANERPATUREV

Structurally Diverse

PELAREOREP

Structurally Diverse

GEBASAXTUREV

Concept

PF-06747143

Concept

SGN-CD123A

Concept

HKT-288

Concept

CDX-3379

Showing 151 - 160 of 183 results

First page
Previous page
16
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1